WILMINGTON, N.C., Sept. 14 /PRNewswire/ — AAIPharma Services
Corp., a leading provider of pharmaceutical product development
services for more than 30 years, announced today that it has
appointed Patrick D. Walsh to chief executive officer. Water
Street, a strategic private equity firm focused exclusively on
health care that acquired AAIPharma Services in a divestiture
transaction from its parent company in 2009, was instrumental in
recruiting Mr. Walsh to the position.
Mr. Walsh, who has nearly 30 years of pharmaceutical
manufacturing experience, will focus on advancing AAIPharma’s next
phase of strategic growth following its establishment as a
standalone company. Mr. Walsh has served in executive roles
at multiple pharmaceutical companies, including as president and
CEO of Kadmus Pharmaceuticals, Inc., and president and COO of
Gensia Sicor. He also served as CEO of a specialty diagnostic
company, and led the U.S. and international business groups for
Fujisawa USA. Most recently, Mr. Walsh founded a management
consulting firm that assisted companies with achieving key
corporate objectives in the pharmaceutical, contract manufacturing
and biotechnology industries.
“Pat has an impressive record of consistently leading
pharmaceutical businesses to achieve high levels of growth over the
course of his career. He is the ideal executive to advance
AAIPharma Services forward, as we focus on pursuing growth
opportunities through a combination of organic initiatives and
strategic acquisitions. Pat’s core skills of business
development, relationship-building, and sales and marketing will
contribute significantly to AAIPharma and our goal of building it
into the leading provider of pharmaceutical development services,”
said Pete Strothman, a principal with Water Street and a member of
AAIPharma Services’ board of directors.
In addition to his executive experience, Mr. Walsh has served on
the boards of director
‘/>”/>
